BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31259569)

  • 1. The dissemination and implementation of contingency management for substance use disorders: A systematic review.
    Oluwoye O; Kriegel L; Alcover KC; McPherson S; McDonell MG; Roll JM
    Psychol Addict Behav; 2020 Feb; 34(1):99-110. PubMed ID: 31259569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contingency Management for Patients Receiving Medication for Opioid Use Disorder: A Systematic Review and Meta-analysis.
    Bolívar HA; Klemperer EM; Coleman SRM; DeSarno M; Skelly JM; Higgins ST
    JAMA Psychiatry; 2021 Oct; 78(10):1092-1102. PubMed ID: 34347030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contingency Management: Using Incentives to Improve Outcomes for Adolescent Substance Use Disorders.
    Stanger C; Budney AJ
    Pediatr Clin North Am; 2019 Dec; 66(6):1183-1192. PubMed ID: 31679606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unexplored equity factor: differential beliefs and attitudes toward contingency management by providers' ethnicity.
    Oluwoye O; Weeks DL; McDonell MG
    BMC Health Serv Res; 2023 Aug; 23(1):902. PubMed ID: 37612684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "I's" on the prize: A systematic review of individual differences in Contingency Management treatment response.
    Forster SE; DePhilippis D; Forman SD
    J Subst Abuse Treat; 2019 May; 100():64-83. PubMed ID: 30898330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of behavioral contingency management in drug abuse treatment.
    Bigelow GE; Stitzer ML; Liebson IA
    NIDA Res Monogr; 1984; 46():36-52. PubMed ID: 6427623
    [No Abstract]   [Full Text] [Related]  

  • 7. Training community-based treatment providers to implement contingency management for opioid addiction: Time to and frequency of adoption.
    Helseth SA; Janssen T; Scott K; Squires DD; Becker SJ
    J Subst Abuse Treat; 2018 Dec; 95():26-34. PubMed ID: 30352667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion of contingency management and attitudes regarding its effectiveness and acceptability.
    Bride BE; Abraham AJ; Roman PM
    Subst Abus; 2010 Jul; 31(3):127-35. PubMed ID: 20687001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of remotely delivered contingency management treatment for substance use.
    Coughlin LN; Salino S; Jennings C; Lacek M; Townsend W; Koffarnus MN; Bonar EE
    J Subst Use Addict Treat; 2023 Apr; 147():208977. PubMed ID: 36804352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Training opioid addiction treatment providers to adopt contingency management: A prospective pilot trial of a comprehensive implementation science approach.
    Becker SJ; Squires DD; Strong DR; Barnett NP; Monti PM; Petry NM
    Subst Abus; 2016; 37(1):134-40. PubMed ID: 26682582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Something of value: the introduction of contingency management interventions into the New York City Health and Hospital Addiction Treatment Service.
    Kellogg SH; Burns M; Coleman P; Stitzer M; Wale JB; Kreek MJ
    J Subst Abuse Treat; 2005 Jan; 28(1):57-65. PubMed ID: 15723733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Research on Contingency Management for Adolescent Substance Use.
    Stanger C; Lansing AH; Budney AJ
    Child Adolesc Psychiatr Clin N Am; 2016 Oct; 25(4):645-59. PubMed ID: 27613343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counselor Attitudes Toward Contingency Management for Substance Use Disorder: Effectiveness, Acceptability, and Endorsement of Incentives for Treatment Attendance and Abstinence.
    Aletraris L; Shelton JS; Roman PM
    J Subst Abuse Treat; 2015 Oct; 57():41-8. PubMed ID: 26001821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative evaluation of a novel contingency management-related intervention for patients receiving supervised injectable opioid treatment.
    Neale J; Tompkins CN; Strang J
    Addiction; 2016 Apr; 111(4):665-74. PubMed ID: 26498274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effectiveness of Ultra-Low Magnitude Reinforcers: Findings From a "Real-World" Application of Contingency Management.
    Kropp F; Lewis D; Winhusen T
    J Subst Abuse Treat; 2017 Jan; 72():111-116. PubMed ID: 27422452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contingency management in outpatient methadone treatment: a meta-analysis.
    Griffith JD; Rowan-Szal GA; Roark RR; Simpson DD
    Drug Alcohol Depend; 2000 Feb; 58(1-2):55-66. PubMed ID: 10669055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. User-centered design of contingency management for implementation in opioid treatment programs: a qualitative study.
    Becker SJ; Scott K; Murphy CM; Pielech M; Moul SA; Yap KR; Garner BR
    BMC Health Serv Res; 2019 Jul; 19(1):466. PubMed ID: 31288797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining implementation of contingency management in real-world settings.
    Rash CJ; Alessi SM; Zajac K
    Psychol Addict Behav; 2020 Feb; 34(1):89-98. PubMed ID: 31343197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
    Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.